首页 > 市场调查报告书 > 医疗设备

生技设备细胞培养

市场调查报告书

商品编码

1621146

实验动物模型、3D 培养、类器官：全球市场

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets

出版日期: 2024年12月17日 | 出版商:

BCC Research | 英文 130 Pages | 订单完成后即时交付

价格

简介目录图表

全球实验动物模型、3D 培养和类器官市场规模预计将从 2024 年的 28 亿美元增加到 2029 年的 50 亿美元，预测期内复合年增长率为 12.5%。

动物模型产业预计将从 2024 年的 18 亿美元增至 2029 年的 32 亿美元，预测期内复合年增长率为 12.2%。 3D细胞培养产业预计将从2024年的10亿美元成长到2029年的19亿美元，复合年增长率为13.2%。

本报告调查了全球实验动物模型、3D培养和类器官市场，并提供了市场概况、市场影响因素和市场机会分析、法律制度、新兴技术和技术发展趋势以及市场规模趋势和预测，按类别及地区、竞争格局、主要企业简介等进行详细分析。

概述
市场驱动因素
关注动物实验的道德替代方案
对肿瘤建模和生物银行的需求增加
扩大类器官技术的广泛应用
市场限制因素
严格的政府法规规范细胞培养和干细胞研究与开发
将类器官纳入现有调查方法的挑战
市场机会
在药物开发、个人化医疗和移植的应用

第四章监管状况

监管场景
美国
欧洲联盟
英国
德国
印度

第五章新兴技术

概述
3D列印
微流体
人工智慧和自动化
专利分析

第六章市场区隔分析

细分细分
全球实验动物模型、3D 培养与类器官市场：依动物模型分类
动物模型
全球市场规模及预测
老鼠
鼠
兔子
仓鼠
天竺鼠
其他的
全球实验动物模型/3D培养/类器官市场：依3D培养
3D文化
全球市场规模及预测
晶片上的器官
类器官
肠
肝
胃
胰臟
肺
肾
其他的
球体
全球实验动物模型、3D 培养和类器官市场：按应用分类
发育生物学
药物发现与个人化医疗
再生医学
感染疾病病理学
测试药物毒性和功效
其他的
地域分布
全球实验动物模型、3D 培养和类器官市场：按地区
全球市场规模及预测
北美洲
美国
加拿大
市场规模及预测
欧洲
德国
英国
市场规模及预测
亚太地区
其他领域

第七章竞争讯息

竞争格局
战略分析

第 8 章实验动物模型、3D 培养与类器官的永续性：ESG 视角

ESG：简介
市场的永续性
ESG观点
环境影响
社会影响
管治

第九章附录

调查方法
简称
来源
公司简介
3D BIOTEK LLC.
BIO-TECHNE
CELLINK
CHARLES RIVER LABORATORIES
CHERRY BIOTECH
CORNING INC.
EMULATE
GENOWAY
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
MATTEK
MIMETAS BV
PEPGEL LLC.
POIETIS
TACONIC BIOSCIENCES INC.
THEWELL BIOSCIENCE INC.
THERMO FISHER SCIENTIFIC INC.

简介目录图表

Product Code: PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

The animal model market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $1.8 billion in 2024 to reach $3.2 billion by 2029, at a CAGR of 12.2% from 2024 through 2029.

The 3D cell culture market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $1.0 billion in 2024 to reach $1.9 billion by 2029, at a CAGR of 13.2% from 2024 through 2029.

Report Scope

The global laboratory animal models, 3D cultures, and organoids market is identified and explored in this report, as are all significant global companies active in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market.

This report analyzes market trends using data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report will highlight current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market shares of key players.

This report details market shares for the different segments, their types and applications, end users, and geography. Based on animal models, the market is segmented into gelatin and vegetarian capsules. The market is segmented based on its nutritional, pharmaceutical, and cosmeceutical applications. Based on end users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies, and others.

The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, and other world regions. The regional segment includes a detailed analysis of major countries such as the U.S., Germany, the U.K., France, Japan, China, and India.

The report's goals include:

Analyzing product types and applications.
Analyzing global market size and segmentation.
Understanding market constraints and drivers.
Providing detailed market forecasts up to 2029.
Assessing market shares, competitiveness, and industry structure.
Identifying potential long-term impacts on the market.

Report Includes

45 data tables and 52 additional tables
An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimation of the actual market size and market forecast for organoids, and their corresponding market share analysis by product type, application, and geographic region
Coverage of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
Review of selected patents and patent applications on organoids, and emerging developments in the global market
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
Assessment of mergers and acquisitions, joint ventures, partnerships, and other market strategies
A discussion of ESG challenges and practices in the industry
Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Corning Inc., genOway, Charles River Laboratories, and Bio-Techne.

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Overview
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry

Chapter 3 Market Dynamics

Overview
Market Drivers
Growing Focus on Ethical Alternatives to Animal Testing
Increasing Demand for Tumor Modeling and Biobanking Fuel Market Expansion
Increasing Adoption of Organoid Technology for Wider Applications
Market Restraints
Strict Government Regulations Governing Cell Cultures and Stem Cells R&D
Challenges in Incorporating Organoids into Existing Research Practices
Market Opportunities
Applications in Drug Development, Personalized Medicine, and Transplantation

Chapter 4 Regulatory Landscape

Regulatory Scenarios
United States
EU
U.K.
Germany
India

Chapter 5 Emerging Technologies

Overview
3D Printing
Microfluidics
Artificial Intelligence and Automation
Patent Analysis

Chapter 6 Market Segmentation Analysis

Segmentation Breakdown
Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Animal Model
Animal Models
Global Market Size and Forecast
Mice
Rats
Rabbits
Hamsters
Guinea Pigs
Others
Global Market for Laboratory Animal Models, 3D Cultures and Organoid, by 3D Cultures
3D Cultures
Global Market Size and Forecast
Organ-on-chip
Organoids
Intestine
Liver
Stomach
Pancreas
Lung
Kidney
Others
Spheroids
Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Application
Developmental Biology
Drug Discovery and Personalized Medicine
Regenerative Medicine
Pathology of Infectious Disease
Drug Toxicity and Efficacy Testing
Others
Geographic Breakdown
Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Region
Global Market Size and Forecast
North America
U.S.
Canada
Market Size and Forecast
Europe
Germany
U.K.
Market Size and Forecast
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Competitive Landscape
Strategic Analysis

Chapter 8 Sustainability in Laboratory Animal Models, 3D Cultures, and Organoids: An ESG Perspective

Introduction to ESG
Sustainability in the Market
ESG Perspective
Environmental Impact
Social Impact
Governance

Chapter 9 Appendix

Methodology
Abbreviations
Sources
Company Profiles
3D BIOTEK LLC.
BIO-TECHNE
CELLINK
CHARLES RIVER LABORATORIES
CHERRY BIOTECH
CORNING INC.
EMULATE
GENOWAY
GREINER BIO-ONE INTERNATIONAL GMBH
INSPHERO
MATTEK
MIMETAS B.V.
PEPGEL LLC.
POIETIS
TACONIC BIOSCIENCES INC.
THEWELL BIOSCIENCE INC.
THERMO FISHER SCIENTIFIC INC.

简介目录图表

List of Tables

Summary Table : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, Through 2029
Table 1 : Animal Model vs. 3D Cell Culture
Table 2 : Porter's Five Forces Analysis: Laboratory Animal Models, 3D Cultures, and Organoids
Table 3 : Patent Analysis for 3D Cell Culture
Table 4 : Global Market for Animal Models, by Animal Type, Through 2029
Table 5 : Global Market for Mice Animal Models, by Region, Through 2029
Table 6 : Global Market for Rat Animal Models, by Region, Through 2029
Table 7 : Global Market for Rabbit Animal Models, by Region, Through 2029
Table 8 : Global Market for Hamster Animal Models, by Region, Through 2029
Table 9 : Global Market for Guinea Pig Animal Models, by Region, Through 2029
Table 10 : Global Market for Other Animal Models, by Region, Through 2029
Table 11 : Global Market for 3D Cell Cultures, by 3D Type, Through 2029
Table 12 : Global Market for Organ-on-chips in 3D Cultures, by Region, Through 2029
Table 13 : Global Market for Organoids in 3D Cultures, by Organ Type, Through 2029
Table 14 : Global Market for Organoid in 3D Cultures, by Region, Through 2029
Table 15 : Global Market for Intestines in Organoids, by Region, Through 2029
Table 16 : Global Market for Livers in Organoids, by Region, Through 2029
Table 17 : Global Market for Stomachs in Organoids, by Region, Through 2029
Table 18 : Global Market for Pancreases in Organoids, by Region, Through 2029
Table 19 : Global Market for Lungs in Organoids, by Region, Through 2029
Table 20 : Global Market for Kidneys in Organoids, by Region, Through 2029
Table 21 : Global Market for Other in Organoids, by Region, Through 2029
Table 22 : Global Market for Spheroids in 3D Cultures, by Region, Through 2029
Table 23 : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Application, Through 2029
Table 24 : Global Market for Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 25 : Global Market for Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 26 : Global Market for Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 27 : Global Market for Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 28 : Global Market for Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 29 : Global Market for Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 30 : Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
Table 31 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 32 : North American Market for 3D Cell Cultures, by Type, Through 2029
Table 33 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 34 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 35 : European Market for 3D Cell Cultures, by Type, Through 2029
Table 36 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 37 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 38 : Asia-Pacific Market for 3D Cell Cultures, by Type, Through 2029
Table 39 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 40 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
Table 41 : Rest of the World Market for 3D Cell Cultures, by Type, Through 2029
Table 42 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
Table 43 : Global Company Rankings in the Market for Laboratory Animal Models, 3D Cultures and Organoids, 2023
Table 44 : Key ESG Metrics Focus Areas
Table 45 : ESG Rankings for CRO Services, 2023
Table 46 : Abbreviations Used in this Report
Table 47 : Report Sources
Table 48 : 3D Biotek LLC.: Company Snapshot
Table 49 : 3D Biotek LLC.: Product Portfolio
Table 50 : Bio-Techne: Company Snapshot
Table 51 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 52 : Bio-Techne: Product Portfolio
Table 53 : Bio-Techne: News/Key Developments, 2022
Table 54 : Cellink: Company Snapshot
Table 55 : Cellink: Product Portfolio
Table 56 : Cellink: News/Key Developments, 2023
Table 57 : Charles River Laboratories: Company Snapshot
Table 58 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
Table 59 : Charles River Laboratories: Products Portfolio
Table 60 : Charles River Laboratories: News/Key Developments, 2023
Table 61 : Cherry Biotech: Company Snapshot
Table 62 : Cherry Biotech: Product Portfolio
Table 63 : Corning Inc.: Company Snapshot
Table 64 : Corning Inc.: Financial Performance, FY 2022 and 2023
Table 65 : Corning Inc.: Product Portfolio
Table 66 : Corning Inc.: News/Key Developments, 2022-2024
Table 67 : Emulate: Company Snapshot
Table 68 : Emulate: Product Portfolio
Table 69 : Emulate: News/Key Developments, 2021-2023
Table 70 : genOway: Company Snapshot
Table 71 : genOway: Financial Performance, FY 2022 and 2023
Table 72 : genOway: Product Portfolio
Table 73 : genOway: News/Key Developments, 2021 and 2022
Table 74 : Greiner Bio-One International GmbH: Company Snapshot
Table 75 : Greiner Bio-One International GmbH: Product Portfolio
Table 76 : InSphero: Company Snapshot
Table 77 : InSphero: Product Portfolio
Table 78 : InSphero: News/Key Developments, 2023
Table 79 : MatTek: Company Snapshot
Table 80 : MatTek: Product Portfolio
Table 81 : Mimetas B.V.: Company Snapshot
Table 82 : Mimetas B.V.: Product Portfolio
Table 83 : Mimetas B.V.: News/Key Developments, 2023-2024
Table 84 : PepGel LLC.: Company Snapshot
Table 85 : PepGel LLC.: Product Portfolio
Table 86 : Poietis: Company Snapshot
Table 87 : Poietis: Product Portfolio
Table 88 : Poietis: News/Key Developments, 2024
Table 89 : Taconic Biosciences Inc.: Company Snapshot
Table 90 : Taconic Biosciences Inc.: Product Portfolio
Table 91 : TheWell Bioscience Inc.: Company Snapshot
Table 92 : TheWell Bioscience Inc.: Product Portfolio
Table 93 : TheWell Bioscience Inc.: News/Key Developments, 2023-2024
Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio

List of Figures

Summary Figure : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, 2021-2029
Figure 1 : Animal Modelling for Drug Discovery
Figure 2 : Evolution of 3D Cell Culture
Figure 3 : Market Dynamics of Laboratory Animal Models, 3D Cultures, and Organoids
Figure 4 : Global Market Shares of Animal Models, by Animal Type, 2023
Figure 5 : Global Market Shares of Mice Animal Models, by Region, 2023
Figure 6 : Global Market Shares of Rat Animal Models, by Region, 2023
Figure 7 : Global Market Shares of Rabbit Animal Models, by Region, 2023
Figure 8 : Global Market Shares of Hamster Animal Models, by Region, 2023
Figure 9 : Global Market Shares of Guinea Pig Animal Models, by Region, 2023
Figure 10 : Global Market Shares of Other Animal Models, by Region, 2023
Figure 11 : Types of 3D Cell Culture Utilized in Drug Discovery
Figure 12 : Global Market Shares of 3D Cell Cultures, by 3D Type, 2023
Figure 13 : Global Market Shares of Organ-on-chips in 3D Cultures, by Region, 2023
Figure 14 : Global Market Shares of Organoids in 3D Cultures, by Organ Type, 2023
Figure 15 : Global Market Shares of Organoid in 3D Cultures, by Region, 2023
Figure 16 : Global Market Shares of Intestines in Organoids, by Region, 2023
Figure 17 : Global Market Shares of Livers in Organoids, by Region, 2023
Figure 18 : Global Market Shares of Livers in Organoids, by Region, 2023
Figure 19 : Global Market Shares of Pancreases in Organoids, by Region, 2023
Figure 20 : Global Market Shares of Lungs in Organoids, by Region, 2023
Figure 21 : Global Market Shares of Kidneys in Organoids, by Region, 2023
Figure 22 : Global Market Shares of Other in Organoids, by Region, 2023
Figure 23 : Global Market Shares of Spheroids in 3D Cultures, by Region, 2023
Figure 24 : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Application, 2023
Figure 25 : Global Market Shares of Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 26 : Global Market Shares of Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 27 : Global Market Shares of Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 28 : Global Market Shares of Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 29 : Global Market Shares of Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 30 : Global Market Shares of Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 31 : Global Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 32 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 33 : North American Market Shares of 3D Cell Cultures, by Type, 2023
Figure 34 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 35 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segmen, 2023
Figure 36 : European Market Shares of 3D Cell Cultures, by Type, 2023
Figure 37 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 38 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 39 : Asia-Pacific Market Shares of 3D Cell Cultures, by Type, 2023
Figure 40 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
Figure 41 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
Figure 42 : Rest of the World Market Shares of 3D Cell Cultures, by Type, 2023
Figure 43 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
Figure 44 : Pillars of ESG
Figure 45 : Advantages of ESG for Companies
Figure 46 : Bio-Techne: Revenue Shares, by Segment, 2023
Figure 47 : Bio-Techne: Revenue Shares, by Country/Region, 2023
Figure 48 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2023
Figure 49 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2023
Figure 50 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 51 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 52 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 53 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023